TY - JOUR
T1 - Management of benign prostatic hyperplasia
AU - Kim, Eric H.
AU - Larson, Jeffrey A.
AU - Andriole, Gerald L.
N1 - Publisher Copyright:
© 2016 by Annual Reviews.
PY - 2016/1/14
Y1 - 2016/1/14
N2 - Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) commonly affect older men. Age-related changes associated with metabolic disturbances, changes in hormone balance, and chronic inflammation may cause BPH development. The diagnosis of BPH hinges on a thorough medical history and focused physical examination, with attention to other conditions that may be causing LUTS. Digital rectal examination and urinalysis should be performed. Other testing may be considered depending on presentation of symptoms, including prostate-specific antigen, serum creatinine, urine cytology, imaging, cystourethroscopy, post-void residual, and pressure-flow studies. Many medical and surgical treatment options exist. Surgery should be reserved for patients who either have failed medical management or have complications from BPH, such as recurrent urinary tract infections, refractory urinary retention, bladder stones, or renal insufficiency as a result of obstructive uropathy.
AB - Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) commonly affect older men. Age-related changes associated with metabolic disturbances, changes in hormone balance, and chronic inflammation may cause BPH development. The diagnosis of BPH hinges on a thorough medical history and focused physical examination, with attention to other conditions that may be causing LUTS. Digital rectal examination and urinalysis should be performed. Other testing may be considered depending on presentation of symptoms, including prostate-specific antigen, serum creatinine, urine cytology, imaging, cystourethroscopy, post-void residual, and pressure-flow studies. Many medical and surgical treatment options exist. Surgery should be reserved for patients who either have failed medical management or have complications from BPH, such as recurrent urinary tract infections, refractory urinary retention, bladder stones, or renal insufficiency as a result of obstructive uropathy.
KW - 5-alpha reductase inhibitors
KW - Adrenergic alpha-antagonists
KW - Lower urinary tract symptoms
KW - Phosphodiesterase type 5 inhibitors
KW - Transurethral resection of prostate
UR - http://www.scopus.com/inward/record.url?scp=84954538465&partnerID=8YFLogxK
U2 - 10.1146/annurev-med-063014-123902
DO - 10.1146/annurev-med-063014-123902
M3 - Article
C2 - 26331999
AN - SCOPUS:84954538465
SN - 0066-4219
VL - 67
SP - 137
EP - 151
JO - Annual review of medicine
JF - Annual review of medicine
ER -